Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
Journal article
Coleman JA. et al, (2024), Cardiovasc Res
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
Journal article
Elneima O. et al, (2024), International Journal of Epidemiology, 53
Photon-Counting Computed Tomography: "One-Stop Shop" For Coronary Stenosis, Inflammation And Myocardial Assessment in STEACS.
Journal article
Kotronias RA. et al, (2024), Eur Heart J Cardiovasc Imaging
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Journal article
Taquet M. et al, (2024), Brain Commun, 6
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review.
Journal article
Singh SJ. et al, (2023), Eur Respir Rev, 32
Synbiotics in post-acute COVID-19 syndrome-a potential new treatment framework?
Journal article
Raman B. and Ramasamy MN., (2023), Lancet Infect Dis
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Journal article
Brightling CE. et al, (2023), Lancet Respir Med, 11, e93 - e94
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Journal article
C-MORE/PHOSP-COVID Collaborative Group None., (2023), Lancet Respir Med, 11, 1003 - 1019
Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain.
Journal article
Raman B., (2023), JACC Cardiovasc Imaging
Erratum for: Lung Abnormalities Detected with Hyperpolarized 129Xe MRI in Patients with Long COVID.
Journal article
Grist JT. et al, (2023), Radiology, 309
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Journal article
Taquet M. et al, (2023), Nat Med
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Journal article
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684
Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
Journal article
Farrant J. et al, (2023), Heart, 109, 1175 - 1182
Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis.
Journal article
Dawson C. et al, (2023), BMJ Open Respir Res, 10
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
Journal article
Coleman JA. et al, (2023), Int J Cardiovasc Imaging
Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
Journal article
Roca-Fernandez A. et al, (2023), J Hepatol
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Journal article
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.
Journal article
Hermida U. et al, (2023), Eur Heart J Cardiovasc Imaging, 24, 807 - 818
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Journal article
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669